Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Follow-up After Metastasectomy in Patients With Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Kidney Tumors in Younger Patients
- Status
- COMPLETED
- Phase
- N/A
An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Exercise for Patients With Renal Cell Cancer Receiving Sunitinib
- Status
- UNKNOWN
- Phase
- PHASE3
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Genetic Susceptibility to Kidney Cancer
- Status
- TERMINATED
- Phase
- N/A
Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent
- Status
- COMPLETED
- Phase
- N/A
VEGF Imaging in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
- Status
- COMPLETED
- Phase
- PHASE1
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- NA